On February 1st, semiconductor company SMIC International released a performance forecast, predicting a comprehensive income total of 2.305 billion to 2.817 billion yuan during the 2022 period, a decrease of 46.7% to 56.4% compared to the same period last year, which saw a total income of 5.287 billion yuan.
International semiconductor manufacturer SMIC expects its adjusted net profit to decline between 46.8% to 56.2%, from RMB 54.43 billion in the same period of the previous year, to RMB 23.85 billion to 28.97 billion in 2022.
Simo International stated that there were several reasons for the decrease in profits.
In the fiscal year of 2022, the group experienced a decline in revenue from both the Chinese and American markets.
The gross profit margin decreased year-on-year due to the reduction in product prices for certain major clients in 2022. Additionally, there was a significant increase in the low gross margin one-time atomization business, which contributed to a higher proportion of the overall business.
According to its established strategy to enhance long-term competitive advantages and cultivate new growth areas, the group has continued to increase research and development (R&D) investment, particularly in the foundational research of atomization technology and investing in the medical and healthcare industries. In the 2022 fiscal year, there has been a significant increase in R&D expenditure compared to the same period last year.
To address the long-term development needs and improve the management and marketing capabilities of the group, investments have been made in aspects such as information systems, organizational and process improvements, marketing systems, and channel development. This has resulted in a significant increase in management and sales expenses compared to the same period last year.
References:
Profit Warning for the Fiscal Year Ending on December 31, 2022.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
